This commentary expresses one of the most difficult areas in all of security sales and practices. The commentary does not relate to unsuitable investments or recommendations of any kind by a broker, since, whether the investments were monitored or not, they were unacceptable from the initial sale and no amount of continued review changes their improper character.
Some investors feel that they are receiving less than objective advice.
And considering the free trips and other miscellaneous incentives offered by many firms and funds, part of the cynicism is justified. As an example, consider Digital Stock. Some investors within the last few years have seen a significant loss. Biotech stocks had done exceedingly well prior to 1992. But they underwent a significant retrenchment after that and suffered some losses.